The global UV infection control devices market was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is rising every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can affect patients seriously. The UV infection control device works base on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

The major factor that contributes to the growth of UV infection control device market include increase in government focus on infection control programs and increase in the prevalence of hospital acquired infections (HAI). Furthermore, other factors that boost UV infection control device market growth include rising adoption of technologically advanced UV equipment. However, high cost of UV infection control devices and stringent government regulations hampers the growth of UV infection control devices market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.

Request for a FREE sample of this market research report@ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR728

The UV infection control devices market size is studied on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

– This report entails a detailed quantitative analysis along with the current global UV infection control devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
– The market size and estimations are based on a comprehensive analysis of key developments in the industry.
– A qualitative analysis based on innovative products facilitates strategic business planning.
– The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
– By Type
o Mobile
o Stationary
o Other types
– By End User
o Hospitals
o Clinics
o Others
– By Region
o North America
– U.S.
– Canada
– Mexico
o Europe
– Germany
– France
– Italy
– Russia
– Rest of Europe
o Asia-Pacific
– Japan
– China
– India
– Rest of Asia-Pacific
– Brazil
– Saudi Arabia
– South Africa
– Rest of LAMEA

Send a request to Report Ocean to understand the structure of the complete report @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR728

– List of key players profiled in the report:
– CVS Health Corporation
– DocMorris
– Express Scripts Holding Company
– Giant Eagle Inc.
– Optum Rx Inc.
– Rowlands Pharmacy
– The Kroger Co.
– Walgreen Co.
– Walmart Stores Inc.
– Apollo Pharmacy

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
– The Miele Group
– Melag Medizintechnik OHG

Back to top button